Replies to post #73421 on ViaDerma Inc (VDRM)

[gameccks1]

I cannot conceive of even a shoe string argument as to how the 95.5M excess shares (6.2% of company, including preferred share impact) could be deemed merited and not insultingly, egregiously unjustified, by non-CEO stockholder, with the reported performance record of CEO, over last nearly a decade.

Note: Licensing is first column. Product sales is second column.